scholarly journals Genital Tract Viral Load in HIV Type 1-Positive Women Correlates with Specific Cytokine Levels in Cervical-Vaginal Secretions But Is Not a Determinant of Infectious Virus or Anti-HIV Activity

2012 ◽  
Vol 28 (11) ◽  
pp. 1533-1539 ◽  
Author(s):  
Lucy R. Mukura ◽  
Mimi Ghosh ◽  
John V. Fahey ◽  
Susan Cu-Uvin ◽  
Charles R. Wira
2016 ◽  
Vol 2016 ◽  
pp. 1-7 ◽  
Author(s):  
Ramadan A. Mahmoud ◽  
Abdel-Azeem M. El-Mazary ◽  
Ashraf Khodeary

Background. Frequent blood transfusions in thalassemia major children expose them to the risk of transfusion-transmitted infections (TTIs). The aim of this study was to estimate the prevalence of hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), and cytomegalovirus (CMV) in thalassemic children attending the Pediatrics Departments of both Sohag and Minia Universities of Upper Egypt, during the period from May 2014 to May 2015.Methods. Serum samples were screened for hepatitis B surface antigen (HBsAg), anti-HCV, anti-CMV, and anti-HIV type 1 and type 2 using the Vitek Immunodiagnostic Assay System.Results. The frequencies of anti-HCV, HBsAg, anti-CMV, and anti-HIV type 1 and type 2 were found to be 37.11%, 4.12%, 4.12%, 0.00%, and 0.00%, respectively. Seropositivity for anti-HCV, HBsAg, and anti-CMV increased with increasing age of the patients, duration of the disease, serum ferritin level (ng/mL), and liver enzymes (U/L), while it was not significantly associated with gender, frequency of blood transfusion, or the status of splenectomy operation (P>0.05).Conclusion. The frequency of TTIs, especially HCV, is considerably high among Egyptian children with thalassemia major. It is therefore important to implement measures to improve blood transfusion screening, such as polymerase chain reaction, in order to reduce TTIs from blood donor units.


Author(s):  
Lun-Quan Sun ◽  
Wayne Gerlach ◽  
Geoff Symonds

1997 ◽  
Vol 13 (8) ◽  
pp. 647-656 ◽  
Author(s):  
AN LI ◽  
TIMOTHY W. BABA ◽  
JOSEPH SODROSKI ◽  
SUSAN ZOLLA-PAZNER ◽  
MIROSLAW K. GORNY ◽  
...  

2009 ◽  
Vol 16 (7) ◽  
pp. 1060-1065 ◽  
Author(s):  
Odd Odinsen ◽  
David Parker ◽  
Frans Radebe ◽  
Mikey Guness ◽  
David A Lewis

ABSTRACT Diagnosis of acute human immunodeficiency virus (HIV) infection, a key driver of the HIV epidemic, remains a public health challenge. The PlasmAcute technology offers an opportunity to detect early anti-HIV antibody responses. B lymphocytes (B cells) were isolated from the blood of seronegative miners in South Africa by using the PlasmAcute method. B-cell lysates and paired sera were tested for anti-HIV-1 antibodies by two different enzyme-linked immunosorbent assays; immunoreactivity was confirmed by Western blotting. All volunteers were tested for HIV type 1 (HIV-1) viral load, p24 antigen, and CD4 count. Sera from HIV-seronegative men who had positive viral loads and were positive for p24 antigen were retested for anti-HIV antibodies after immune complex dissociation. Anti-HIV antibodies were detected in lysates from 16/259 subjects without immunoreactivity in paired sera. Four subjects, one of whom had a positive viral load initially, subsequently seroconverted. Six subjects showed transient anti-HIV-1 antibodies in the lysates and tested negative for all markers at the follow-up. Five subjects without follow-up data initially had lysate-positive/serum-negative samples, and these cases were classified as inconclusive. One subject had lysate antibodies and a detectable viral load but was seronegative at follow-up. In conclusion, lysate-derived anti-HIV-1 B-cell antibodies can be detected prior to seroconversion and earlier than or contemporary with HIV-1 RNA detection.


1999 ◽  
Vol 123 (11) ◽  
pp. 1011-1014
Author(s):  
Frederick S. Nolte

Abstract Quantitative human immunodeficiency virus (HIV) type 1 RNA tests have been essential tools in increasing our understanding of HIV pathogenesis and antiretroviral therapy. The plasma HIV RNA level is among the most powerful predictive tests in modern medicine for disease progression and has rapidly become the standard of practice for guiding clinicians in initiating, monitoring, and changing antiretroviral therapy. In this article the scientific rationale and clinical indications for viral load testing in HIV infection are reviewed.


2012 ◽  
Vol 28 (11) ◽  
pp. 1524-1532 ◽  
Author(s):  
Richard E. Haaland ◽  
Sharon T. Sullivan ◽  
Tammy Evans-Strickfaden ◽  
Jeffrey L. Lennox ◽  
Clyde E. Hart

1997 ◽  
Vol 13 (4) ◽  
pp. 327-335 ◽  
Author(s):  
S.M. BRUISTEN ◽  
P.H.J. FRISSEN ◽  
P. VAN SWIETEN ◽  
P.R. HARRIGAN ◽  
I. KINGHORN ◽  
...  

1999 ◽  
Vol 15 (14) ◽  
pp. 1241-1247 ◽  
Author(s):  
Johan R. Boelaert ◽  
Kirk Sperber ◽  
Jacques Piette
Keyword(s):  

2004 ◽  
Vol 20 (2) ◽  
pp. 145-150 ◽  
Author(s):  
Kira K. Lueders ◽  
Stephen C. De Rosa ◽  
Antonio Valentin ◽  
George N. Pavlakis ◽  
Mario Roederer ◽  
...  
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document